Taro Pharmaceutical Industries Ltd
NYSE:TARO
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Price:
42.4 USD
-0.19%
Market Closed
Updated:
Apr 28, 2024
Taro Pharmaceutical Industries Ltd
Net Income (Common)
|
Taro Pharmaceutical Industries Ltd
Net Income (Common) Peer Comparison
Comparables:
T
TEVA
I
INCR
MDWD
R
REKA
C
CSURE
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Taro Pharmaceutical Industries Ltd
NYSE:TARO
|
Net Income (Common)
$45.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-18%
|
|
T
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Net Income (Common)
-$559m
|
CAGR 3-Years
48%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
I
|
InterCure Ltd
TASE:INCR
|
Net Income (Common)
₪20.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-8%
|
|
|
Mediwound Ltd
NASDAQ:MDWD
|
Net Income (Common)
-$6.7m
|
CAGR 3-Years
10%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
8%
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Net Income (Common)
-₪8.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-62%
|
CAGR 10-Years
N/A
|
|
C
|
Cannassure Therapeutics Ltd
TASE:CSURE
|
Net Income (Common)
-₪5.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Taro Pharmaceutical Industries Ltd's Net Income (Common)?
Net Income (Common)
45.6m
USD
45.6m
USD
Based on the financial report for Dec 31, 2023, Taro Pharmaceutical Industries Ltd's Net Income (Common) amounts to 45.6m USD.
What is Taro Pharmaceutical Industries Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-18%
-18%
Over the last year, the Net Income (Common) growth was -1%.
You don't have any saved screeners yet
